Changing the Treatment Paradigm in Type 2 Diabetes Mellitus: Insights into the Evolving Role of SGLT2 Inhibitors


Date: Sep 6, 2024 09:00 AM - 10:00 AM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Sep 20, 2024 01:00 AM

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

   

Objectives

  • Classify the types of SGLT2 inhibitors and their mechanisms.
  • Describe the benefits and risks associated with SGLT2 inhibitors in the management of T2DM.
  • Identify appropriate patient populations who would benefit most from SGLT2 inhibitor therapy.

Speaker(s)/Author(s)

Dinka D. Iticha, RPh, MSc, Lecturer
Wollega University

Activity Number

0010-9999-24-046-L01-P
Date: 09/06/24
Time: 09:00 AM - 10:00 AM

CE Hours

1.00